Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

04/20/2012 | 08:16pm US/Eastern

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

XIANYANG, China, April 20, 2012/PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in Chinafor a variety of diseases and conditions, today announced that it has received written notification from the Nasdaq Listing Qualifications department that it has regained compliance with the minimum bid price requirement of $1.00per share for continued listing of its common stock on The NASDAQ Global Market set forth in Nasdaq Listing Rule 5450(a)(1), as its common shares achieved a closing bid price of $1.00or more for 10 consecutive business days prior to the compliance deadline of April 23, 2012and this matter is now closed.

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com

Safe Harbor relating to the Forward-Looking Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company uses words and phrases such as "guidance," "forecasted," "projects," "is expected," "remain confident," "will" and similar expressions to identify forward-looking statements in this press release, including forward-looking statements. Undue reliance should not be placed on forward-looking information. Forward-looking information is based on current expectations, estimates and projections that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Biostar and described in the forward-looking information contained in this news release. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the Company's ability to maintain its ongoing compliance with the Nasdaq continued listing requirements, success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, its ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, its ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our most recent Annual Report on Form 10-K for the year ended December 31, 2011, and other subsequent filings. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

For more information contact:




BioStar Pharmaceuticals, Inc. 

The Equity Group, Inc.

Zack Pan, CFO 

Lena Cati

Tel: 405-996-8829 

Tel: 212 836-9611

Email: zpan@aoxing-group.com

Email: lcati@equityny.com

SOURCE Biostar Pharmaceuticals, Inc.

distributed by
React to this article
Latest news
Date Title
11:05p MICHELIN CGDE : Master of the knife
11:05p TAKASHIMAYA : Top Japanese cooking school opens here
11:04p CBRE : Inside Invest
11:03p CBRE : London rental market enjoying revival
11:03p RENAULT : in the MPV Race
11:02p BAYERISCHE MOTOREN WERKE : BMW Experience Tour in Gurgaon
11:02p NTPC : 'NTPC will become a 1,28,000-MW corporation by 2032'
11:02p AUDI : Technical Service Centre Drives into Mumbai
10:59p CALIFORNIA BANK OF COMMERCE : Chris Morin Joins as EVP and Market President for Santa Clara Region
10:57p Europe is protected from possible Greek problems, France says
Latest news
Advertisement
Hot News 
OPPORTUNITY INVEST MGMT : 16 April 2015 - Update didivend payment
BEOWULF MINING : TR-1: Notification of Major Interest in Shares
TROVAGENE : Nasdaq stocks posting largest percentage increases
INSPIRIT ENERGY : Issue of Equity and Directors' Dealings 02 April 2015
GAMEACCOUNT NETWORK : DIRECTOR DEALINGS: GameAccount Non-Executive Buys 100,000 Shares
Most Read News
06:12p Communique of IMF steering committee
07:51p Conservatives aim to sell Lloyds shares to small investors
07:55p BANK OF MONTREAL : BMO Capital Markets and Variety Village : Unveil Playground for Children of All Abilities
07:35p NATIONAL GRID : Electricity pylons: our need for energy must not overwhelm the landscape
06:19p BAYERISCHE MOTOREN WERKE : Manu Codjia Trio winner of BMW Welt Jazz Award 2015. Series of concerts to be continued in 2016 following the motto “Inspired by Legends”.
Most recommended articles
10:57p Europe is protected from possible Greek problems, France says
07:51p Conservatives aim to sell Lloyds shares to small investors
06:12p Ghana's IMF programme likely to free up other lending - Lagarde
06:12p Communique of IMF steering committee
06:12p IMF, World Bank 2015 spring meetings in Washington on Saturday
Dynamic quotes  
ON
| OFF